Limbic encephalitis in metastatic malignant melanoma patient induced by PD-1 checkpoint inhibitor pembrolizumab
This case report presents a patient with metastatic malignant melanoma who was treated with immunotherapy with the PD-1 checkpoint inhibitor pembrolizumab and developed a rare neurological immune-related adverse event (irAE) limbic encephalitis. Despite successful treatment of irAE, the neurological...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2022-07-01
|
| Serie: | Advances in Cancer Biology - Metastasis |
| Soggetti: | |
| Accesso online: | http://www.sciencedirect.com/science/article/pii/S2667394021000265 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|